REGN
Regeneron Pharmaceuticals Inc
788.00$
-1.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 33.1% | 31.7% | 48.1% | 10.0% | 34.7% | 33.3% | 34.5% | 31.1% | 43.1% | 30.1% | 29.9% | 13.4% | 28.6% | |
| 3.1% | 3.3% | 3.6% | 3.4% | 3.3% | 3.3% | 4.2% | 3.7% | 3.6% | 3.7% | 3.4% | 2.9% | 3.4% | |
| 6.1% | 7.0% | 7.3% | 6.3% | 6.0% | 8.0% | 8.4% | 6.8% | 6.3% | 6.4% | 7.1% | 5.7% | 6.4% | |
| -5.7% | -1.8% | 14.0% | -25.6% | 12.6% | -2.3% | 4.3% | -6.2% | 16.6% | 0.2% | -2.1% | -3.8% | 2.5% | |
| 5.2% | 9.1% | 5.1% | 5.9% | 4.9% | 7.0% | 9.0% | 4.8% | 5.4% | 6.4% | 6.4% | 5.6% | 5.9% | |
| -14.8% | -1.9% | -53.6% | -15.7% | -15.4% | 9.3% | 21.4% | -29.8% | -10.7% | 5.7% | -11.9% | -2.2% | -4.5% | |
| – | – | 0.0% | 0.0% | – | – | 3.1% | 2.5% | 2.4% | 2.4% | 2.7% | 2.3% | 2.4% | |
| -20.1% | -21.8% | -9.3% | -17.0% | -19.8% | -25.7% | -34.5% | -28.9% | -17.7% | -17.3% | -22.0% | -27.3% | -21.2% | |
| -12.1% | -13.0% | 1.5% | -13.5% | -17.0% | -30.0% | -36.0% | -30.7% | -19.1% | -20.1% | -22.2% | -54.6% | -29.9% | |
| 6.3% | 16.8% | -4.1% | -19.2% | 2.2% | 12.6% | 19.9% | -29.3% | 13.3% | 15.7% | -4.2% | -43.4% | -5.8% | |
| 27.9% | 22.6% | 42.9% | 4.0% | 29.8% | 26.3% | 25.5% | 26.3% | 37.8% | 23.7% | 23.5% | 7.8% | 22.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.